AbbVie ABBV
NYSE ABBV
$285.37 +1.97 (+0.70%)
As of: Oct 16, 2026 · 3:59 PM EDT

AbbVie (ABBV) Cash & Current Investments (2012 - 2026)

Updated

AbbVie's Cash & Current Investments came in at $6.57 billion for Q2 2026, up 1.6% from $6.47 billion a year earlier but down 30.1% from the prior quarter.

Analysis

AbbVie (ABBV) Cash & Current Investments (2012 - 2026) Analysis & Trends

At the end of FY2025, AbbVie's Cash & Current Investments was $5.26 billion, down 5.4% from FY2024.

  • Cash & Current Investments carries a five-year compound annual growth rate of -9.1% (FY2020 to FY2025).
  • Going back by year, Cash & Current Investments was $5.56 billion in FY2024 (-56.7%), $12.82 billion in FY2023 (+38.9%), $9.23 billion in FY2022 (-6.1%) and $9.83 billion in FY2021 (+15.9%).
  • The five-year range for quarterly Cash & Current Investments is $5.18 billion (Q1 2025) to $18.07 billion (Q1 2024).
  • Year-over-year, Cash & Current Investments increased in two of the last eight quarters, with an average decline of 21.1%.
  • The fastest year-over-year change in Cash & Current Investments over five years came in Q1 2024 (growth of 168.8%), and the weakest in Q1 2025 (a decline of 71.4%).
  • Business Quant data shows ABBV's Cash & Current Investments at $9.39 billion (Q1 2026), $5.26 billion (Q4 2025) and $5.67 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 20.76 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn 6.57 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 4.90 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn 3.18 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn 11.70 Bn
10 Vertex Pharmaceuticals 126.70 Bn 98.70 Bn 2.84 Bn 7.85 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.57 Bn
Mar 31, 2026 9.39 Bn
Dec 31, 2025 5.26 Bn
Sep 30, 2025 5.67 Bn
Jun 30, 2025 6.47 Bn
Mar 31, 2025 5.18 Bn
Dec 31, 2024 5.56 Bn
Sep 30, 2024 7.29 Bn
Jun 30, 2024 13.16 Bn
Mar 31, 2024 18.07 Bn
Dec 31, 2023 12.82 Bn
Sep 30, 2023 13.29 Bn
Jun 30, 2023 8.77 Bn
Mar 31, 2023 6.72 Bn
Dec 31, 2022 9.23 Bn
Sep 30, 2022 11.88 Bn
Jun 30, 2022 9.96 Bn
Mar 31, 2022 7.57 Bn
Dec 31, 2021 9.83 Bn
Sep 30, 2021 12.25 Bn
API Access

AbbVie Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ABBV&period=max&api_key=YOUR_API_KEY